These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 3051487)

  • 21. Fetal liver transplantation in immunodeficiencies and inborn errors of metabolism.
    Touraine JL; Roncarolo MG; Marseglia GL; Souillet G; Bétend B; Bétuel H; Touraine F; Royo C; Philippe N; François R
    Prog Clin Biol Res; 1985; 193():299-313. PubMed ID: 3937157
    [No Abstract]   [Full Text] [Related]  

  • 22. Acquired immunologic deficiencies after trauma and surgical procedures.
    Howard RJ; Simmons RL
    Surg Gynecol Obstet; 1974 Nov; 139(5):771-82. PubMed ID: 4154512
    [No Abstract]   [Full Text] [Related]  

  • 23. Tumor induction by immunologically activated murine leukemia virus: cellular immunity early in the graft-vs-host reaction.
    Ruddle NH; Armstrong MY; Richards FF
    J Immunol; 1974 Feb; 112(2):706-15. PubMed ID: 4149884
    [No Abstract]   [Full Text] [Related]  

  • 24. Immunological enhancement of renal allografts.
    Stuart FP; McKearn TJ; Fitch FW
    Transplant Proc; 1974 Dec; 6(4 Suppl 1):53-8. PubMed ID: 4140597
    [No Abstract]   [Full Text] [Related]  

  • 25. Graft vs graft reaction resulting in the elimination of maternal cells in a SCID patient with maternofetal GVHd after an HLA identical bone marrow transplantation.
    Le Deist F; Raffoux C; Griscelli C; Fischer A
    J Immunol; 1987 Jan; 138(2):423-7. PubMed ID: 3540121
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Reconstitution of cell-mediated immunity in severe combined immunodeficiency following fetal liver transplantation.
    Seto S; Miyake T; Hirao T
    Tokai J Exp Clin Med; 1985 Jun; 10(2-3):233-8. PubMed ID: 3914746
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Cellular and humoral mechanisms in graft rejection].
    Blanco A; Gómez-Carrasco JA
    An Esp Pediatr; 1989 Sep; 31 Suppl 39():123-6. PubMed ID: 2490314
    [No Abstract]   [Full Text] [Related]  

  • 28. Cellular engineering through marrow transplantation.
    Good RA; Kapoor N; Day NK; Reisner Y
    Prog Clin Biol Res; 1984; 149():271-98. PubMed ID: 6146143
    [No Abstract]   [Full Text] [Related]  

  • 29. A comparative review of the results of transplants of fully allogeneic fetal liver and HLA-haplotype mismatched, T-cell depleted marrow in the treatment of severe combined immunodeficiency.
    O'Reilly RJ; Kirkpatrick D; Kapoor N; Collins N; Brochstein J; Kernan N; Flomenberg N; Pollack M; Dupont B; Lopez C
    Prog Clin Biol Res; 1985; 193():327-42. PubMed ID: 3911216
    [No Abstract]   [Full Text] [Related]  

  • 30. Effect of nutritional status on immune phenomena.
    Worthington BS
    J Am Diet Assoc; 1974 Aug; 65(2):123-9. PubMed ID: 4858389
    [No Abstract]   [Full Text] [Related]  

  • 31. Transplantation of HLA-mismatched marrow depleted of T-cells by lectin agglutination and E-rosette depletion.
    O'Reilly RJ; Collins N; Dinsmore R; Kernan N; Siena S; Brochstein J; Kirkpatrick D; Flomenberg N; Shank B; Dupont B
    Tokai J Exp Clin Med; 1985 Jun; 10(2-3):99-107. PubMed ID: 3914748
    [No Abstract]   [Full Text] [Related]  

  • 32. Graft-versus-host disease.
    Gatti RA; Kersey JH; Yunis EJ; Good RA
    Prog Clin Pathol; 1973; 5():1-18. PubMed ID: 4150104
    [No Abstract]   [Full Text] [Related]  

  • 33. Immune reconstitution with donor-derived memory/effector T cells after orthotopic liver transplantation.
    Collins RH; Sackler M; Pitcher CJ; Waldrop SL; Klintmalm GB; Jenkins R; Picker LJ
    Exp Hematol; 1997 Feb; 25(2):147-59. PubMed ID: 9015215
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Donor-specific HLA-antibody-mediated humoral rejection in a liver transplant recipient fully reversed with plasmapheresis and immunoglobulin.
    Schadde E; d'Alessandro AM; Musat AI; Torrealba JR; Knechtle SJ
    Clin Transpl; 2006; ():479-82. PubMed ID: 18365407
    [No Abstract]   [Full Text] [Related]  

  • 35. Thymus graft in four children: clinical and immunological results.
    Rezza E; Aiuti F; Businco L; Gatti R
    Boll Ist Sieroter Milan; 1974; 53(1):suppl:271. PubMed ID: 4369381
    [No Abstract]   [Full Text] [Related]  

  • 36. Defective expression of mononuclear cell membrane HLA antigens associated with combined immunodeficiency: impaired cellular interactions.
    Zegers BJ; Heijnen CJ; Roord JJ; Kuis W; Schuurman RK; Stoop JW; Ballieux RE
    Birth Defects Orig Artic Ser; 1983; 19(3):93-6. PubMed ID: 6228275
    [No Abstract]   [Full Text] [Related]  

  • 37. Strategy of clinical bone-marrow transplantations with emphasis on treatment of combined immune deficiency.
    van Bekkum DW
    Transplant Proc; 1974 Dec; 6(4):373-7. PubMed ID: 4155154
    [No Abstract]   [Full Text] [Related]  

  • 38. Partial reconstitution of TNP-Ficoll responses and IgG3 expression in Xid mice undergoing graft-vs-host reaction.
    Golding H; Foiles PG; Rittenberg MB
    J Immunol; 1982 Dec; 129(6):2641-6. PubMed ID: 6982935
    [No Abstract]   [Full Text] [Related]  

  • 39. [Graft vs host reaction (GvHR) following perinatal maternofetal transfusion or following blood cell substitution: the diagnostic value of HLA testing].
    Goldmann SF; Ebell W; Blütters-Sawatzki R; Eiermann T; Kreth W; Wölpl A; Friedrich W
    Beitr Infusionther Klin Ernahr; 1987; 18():321-5. PubMed ID: 3439986
    [No Abstract]   [Full Text] [Related]  

  • 40. Bone-marrow transplantation in combined immunodeficiency disease.
    Dooren LJ
    Boll Ist Sieroter Milan; 1974; 53(1):suppl:245-58. PubMed ID: 4152798
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.